Cherry Creek Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$326K Buy
2025
Q2
$325K Buy
2025
Q1
$336K Buy
2024
Q4
$420K Buy
2024
Q3
$378K Sell
2024
Q2
$700K Buy
2024
Q1
$574K Buy
2023
Q4
$176K Buy